Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01379313
Other study ID # 2011-04-007
Secondary ID
Status Completed
Phase N/A
First received June 21, 2011
Last updated September 27, 2012
Start date June 2011
Est. completion date March 2012

Study information

Verified date September 2012
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure. The investigators tried to evaluate the effect of various inspiratory to expiratory ratio on pulmonary gas exchange by randomized controlled trial.


Description:

In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure. During the laparoscopic surgery with abdominal gas insufflation, gas exchange disturbance such as CO2 retention, hypoxemia occurs in addition to high plateau airway pressure. The usual strategy against these kinds of problem is pressure-controlled ventilation. However, the gas exchange problem especially CO2 retention can not be solved in some cases. The inverse-ratio ventilation (IRV), which prolongs the inspiratory time greater than expiratory time, can be applied for adult respiratory distress syndrome. The efficacy of IRV is to improve gas-exchange status by increasing mean airway pressure and alveolar recruitment. There have been several clinical investigations which applied IRV during general anesthesia. However, there have been debates about the effect of IRV during general anesthesia. Therefore, we tried to apply the IRV for subjects undergoing laparoscopic surgery, and evaluate the effect of different I:E ratio on the pulmonary gas exchange and respiratory mechanics.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date March 2012
Est. primary completion date March 2012
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- patients undergoing elective gynecologic laparoscopic surgery

- the duration of pneumoperitoneum during laparoscopic surgery is more than 40 minutes

Exclusion Criteria:

- ASA (American society of anesthesiologists) classification of the subjects more than III.

- Age under 20, or more than 65 years.

- Past history of pneumothorax, COPD, asthma.

- Patients with ischemic heart disease, valvular heart disease.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)


Intervention

Procedure:
conventional I:E ratio
conventional I:E ratio of 1:2 is applied.
1:1 ratio
I:E ratio of 1:1 is applied.
2:1 group
Inverse I:E ratio of 2:1 is applied.
external PEEP
external positive end-expiratory pressure of 5 cmH2O is applied.

Locations

Country Name City State
Korea, Republic of Samsung Seoul Hospital, Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary arterial CO2 partial pressure arteial CO2 partial pressure 10 minutes after induction of general anesthesia No
Primary arterial CO2 partial pressure arteial CO2 partial pressure 30 minutes after start of pneumoperitoneum No
Primary arterial CO2 partial pressure arteial CO2 partial pressure 60 minutes after start of pneumoperitoneum No
Secondary arterial O2 partial pressure arterial O2 partial pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary Mean airway pressure Mean airway pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary tidal volume (setting) tidal volume (setting) 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary hemodynamic parameters systolic/ diastolic blood pressure, heart rate, mean blood pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum Yes
Secondary end-tidal CO2 partial pressure end-tidal CO2 partial pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary respiratory compliance Dynamic compliance, Static compliance 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary Dead space physiologic dead space / tidal volume (VD/VT) 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary work of breathing work of breathing 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary peak inspiratory pressure peak inspiratory pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary plateau pressure plateau pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary positive end-expiratory pressure positive end-expiratory pressure 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary tidal volume (exhaled) tidal volume (exhaled) 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
Secondary minute ventilation minute ventilation 10 min after induction, 30 and 60 min after start of pneumoperitoneum No
See also
  Status Clinical Trial Phase
Completed NCT01937104 - ONSD According to the Position During Laparoscopy N/A
Completed NCT01984632 - Barbed Suture in Single-port Laparoscopic Myomectomy Phase 3
Completed NCT01492179 - Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. Phase 4
Recruiting NCT06099977 - Binaural Sound for Remimazolam Induction N/A
Completed NCT05086770 - Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere N/A
Withdrawn NCT03156127 - A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet Phase 1
Completed NCT05108597 - Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy Phase 3
Completed NCT02392585 - Single or Triple Uterine Tourniquet at Myomectomy N/A
Completed NCT02086435 - Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes N/A
Completed NCT04279626 - Surgical Outcome of Two-port Laparoscopic Myomectomy
Completed NCT01873378 - GnRH Agonist Pretreatment in Hysteroscopic Myomectomy N/A
Completed NCT01064128 - Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic Hysterectomy Phase 3
Recruiting NCT01267851 - Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Completed NCT01542658 - Comparison of Robot-assisted Laparoscopic Myomectomy With Traditional Laparoscopic Myomectomy N/A
Recruiting NCT02631278 - Radio Frequency Ablation (RFA STUDY ) N/A
Recruiting NCT01637974 - Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery N/A
Recruiting NCT01483417 - Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy Phase 3
Recruiting NCT02563392 - Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers? N/A
Completed NCT02056717 - Use of Dexamethasone in Uterine Artery Embolization N/A